Mannitol Salt Agar (MSA) Dry Powder for Staphylococcus Aureus Isolation

Name: Mannitol Salt Agar (MSA) Dry Powder for Staphylococcus Aureus Isolation
Brand: Jinan Babio Biotechnology Co., Ltd.
SKU: 2324636405

Shandong, ChinaJinan Babio Biotechnology Co., Ltd.

US$17.00-40.00

20 pieces

Product profile

Customization

Available

Classification

Biochemical Reagents

Specific Usage

For Biological Purpose, For Microbiological

Model NO.

MSA

Content

Standard

Usage

Laboratory Reagents, Analytical Reagents, Diagnostic Reagents, Teaching Reagents

Source

Dry Powder

Habit Appellation

Fine Chemicals

Application

Industry, Scientific Research, Health, Environmental Protection, Agriculture

Property

Biochemical Reagent

Shelf Life

3 Years

Form

Dry Powder

Storage Condition

Store in Cool, Dry, Dark and Sealed Place

Solubility

Soluble in Distilled Water After Heating

Quality Standard

Microbiological Testing Standard

Brand

Babio

Delivery Time

7-20 Working Days

Specification

250g/bottle; 500g/bottle

Trademark

Babio

Origin

China

Production Capacity

50000 Pieces/Year

Key features

Designed for selective isolation of Staphylococcus aureus in drugs and biological-product samples, high-salt formula inhibits most unwanted bacteria effectively.

Strict quality control for every batch, reliable experimental results for quality-control laboratories.

Dehydrated dry-powder type, long storage life of 3 years, convenient for international shipment and bulk stocking for distributors.

Company profile

Importers and ExportersYears of Export ExperienceExhibition ExperienceProduct Certification

Jinan Babio Biotechnology Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableAverage Response Time: ≤4.28h

AI-Powered supplier vetting

SummaryJinan Babio Biotechnology Co., Ltd. is identified as a professional high-tech supplier specializing in culture media and in vitro diagnostic reagents, including culture medium, virus transport medium, Petri dishes, and Amies medium. Evidence indicates R&D capability, available SDK support, 3D software design services, and broad customization options. The supplier reports qualified service suppliers, documented service procedures, corrective and preventive action procedures, inventory capability, and lead times within 15 working days in both off-season and peak season. It has valid manufacturing contracts with associated subcontractors and traceability procedures. However, it lacks overseas warehouse and showroom capabilities, and its quality-control section explicitly reports no quality assurance. Certification evidence is limited to CE. No customer cases are provided, and financial information is limited to reporting years rather than performance figures.

Supplier typeThe supplier is described as a professional high-tech enterprise focused on R&D, production, and sales of culture media and in vitro diagnostic reagents. Its stated business scope also covers laboratory consumables, biological agents, laboratory equipment, and related products, while the company type is recorded as combined and it is not an offshore company.

CertificationsThe supplier has documented sustainable-development and product certification capability through CE certification. No additional certifications are identified in the provided information.

After-Sales capabilityThe supplier has a documented customer-complaint procedure with followed records, service-capability procedures and corrective/preventive-action records, inventory capability, and stated lead times within 15 working days in both peak and off-season. However, it lacks overseas warehouse and overseas showroom capabilities, so the evidence supports service-process capability but not comprehensive overseas support.

R&D capabilityThe supplier is explicitly identified as having professional R&D capability, available SDK support, and 3D software design services. Its company description also states that it specializes in research and development of culture media and in vitro diagnostic reagents, providing direct evidence of innovation-related capability.

Production capacityThe supplier engages in production of culture media, in vitro diagnostic reagents, laboratory consumables, and biological agents, and reports valid contracts with its factory and each associated subcontractor. Inventory capability, 60 qualified service-capability suppliers, documented procedures, and lead times within 15 working days further support operational capacity, although detailed production-scale data is not provided.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, minor customization, full customization, and flexible customization. It also provides 3D software design services, supporting both design-led and specification-led customization.